| Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial |
Christiniveiga |
Oct 7, 2016 6:03:48 PM |
| Common variants of HTR3 genes are associated with obsessive-compulsive disorder and its phenotypic expression |
PanameñoAl |
Oct 7, 2016 5:37:12 PM |
| Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study: Riluzole in the treatment of OCD |
PanameñoAl |
Oct 7, 2016 5:35:05 PM |
| Genetic association studies in obsessive-compulsive disorder |
juanlandos |
Oct 7, 2016 5:19:34 PM |
| Imaging genetics in obsessive-compulsive disorder: Linking genetic variations to alterations in neuroimaging |
PanameñoAl |
Oct 7, 2016 3:40:54 AM |
| Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement? |
PanameñoAl |
Oct 7, 2016 3:26:10 AM |
| Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement? |
PanameñoAl |
Oct 7, 2016 3:26:02 AM |
| Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms... - PubMed - NCBI |
PanameñoAl |
Oct 7, 2016 3:21:36 AM |
| Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement? - PubMed - NCBI |
PanameñoAl |
Oct 7, 2016 2:32:55 AM |
| A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, A... - PubMed - NCBI |
PanameñoAl |
Oct 7, 2016 2:33:07 AM |
